Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for Paclitaxel-Induced Neuropathy in Breast Cancer
NCT02360059Phase 2Terminated
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Oct 2015
- Primary completion
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of metformin in chemotherapy-induced peripheral neuropathy (CIPN), sponsored by University of Texas MD Anderson Cancer Center. Started Oct 2015; status: terminated.
02
Drugs
metformin
03
Conditions
chemotherapy-induced peripheral neuropathy (CIPN)
Beyond the preview
Go deeper on NCT02360059.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02360059.